These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 70364)
1. Failure of T cells specific for strong histocompatibility antigens to cooperate with B cells for a humoral response. Dennert G; De Rose M; Allen RS Eur J Immunol; 1977 Jul; 7(7):487-92. PubMed ID: 70364 [TBL] [Abstract][Full Text] [Related]
2. Major histocompatibility complex-restricted and unrestricted T helper cells recognizing minor histocompatibility antigens of B cell surfaces. Coutinho A; Augustin AA Eur J Immunol; 1980 Jul; 10(7):535-41. PubMed ID: 6157541 [TBL] [Abstract][Full Text] [Related]
3. Effects of two bisdioxopiperazines on mouse B-and T-cell function. Dennert G; Hatlen LE; Tucker DF J Natl Cancer Inst; 1975 Mar; 54(3):621-9. PubMed ID: 804564 [TBL] [Abstract][Full Text] [Related]
4. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level. Sensi M; Orosz CG; Bach FH J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778 [TBL] [Abstract][Full Text] [Related]
5. Continuously proliferating T killer cells specific for H-2b targets: selection and characterization. Dennert G; De Rose M J Immunol; 1976 Jun; 116(6):1601-6. PubMed ID: 58039 [TBL] [Abstract][Full Text] [Related]
6. Augmentation of syngeneic tumor-specific immunity by semiallogeneic cell hybrids. Toffaletti DL; Darrow TL; Scott DW J Immunol; 1983 Jun; 130(6):2982-6. PubMed ID: 6189910 [TBL] [Abstract][Full Text] [Related]
7. Immune dysfunction associated with graft-vs-host reaction in mice transplanted across minor histocompatibility barriers. II. Reversible defect in T-dependent antibody responses. Budhecha S; Hamilton BL J Immunol; 1989 Jun; 142(11):3740-5. PubMed ID: 2523932 [TBL] [Abstract][Full Text] [Related]
8. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro. Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374 [TBL] [Abstract][Full Text] [Related]
9. Induction and properties of cytotoxic T cells specific for hapten-coupled tumor cells. Dennert G; Hatlen LE J Immunol; 1975 Jun; 114(6):1705-12. PubMed ID: 805174 [TBL] [Abstract][Full Text] [Related]
10. Mapping of SJL/J reticulum cell sarcoma tumor-associated Ia antigens by T cell hybridomas: characterization of tumor-specific and shared epitopes detected on IE+ allogeneic cells. Ohnishi K; Bonavida B J Immunol; 1986 Jul; 137(2):733-40. PubMed ID: 2424977 [TBL] [Abstract][Full Text] [Related]
11. Activation requirements of cloned inducer T cells. I. Differential inhibition by anti-L3T4 or anti-I-A is determined by the accessory cell population. DeKruyff R; Clayberger C; Cantor H; Dorf ME J Immunol; 1985 Oct; 135(4):2243-8. PubMed ID: 3897372 [TBL] [Abstract][Full Text] [Related]
12. T cell tolerization in vitro: modulation of helper and suppressor cell activities. Bleux C; Liacopoulos P; Couderc J; Kanellopoulos-Langevin C J Immunol; 1987 Jul; 139(2):338-45. PubMed ID: 2439586 [TBL] [Abstract][Full Text] [Related]
13. Capacity of different cell types to stimulate cytotoxic T lymphocyte precursor cells in the presence of interleukin 2. Dröge W; Moyers C; Wehrmaker A; Schmidt H; Panknin S; Männel D; Falk W J Immunol; 1984 Jun; 132(6):2749-59. PubMed ID: 6233360 [TBL] [Abstract][Full Text] [Related]
14. The humoral response of mouse spleen cells to two types of sheep erythrocytes. II. Evidence for gene expression in the B lymphocyte. McCarthy MM; Dutton RW J Immunol; 1975 Nov; 115(5):1322-6. PubMed ID: 1080778 [TBL] [Abstract][Full Text] [Related]
15. Evidence for a T suppressor cell-inducing antigenic determinant shared by ADJ-PC-5 plasmacytoma and syngeneic BALB/c spleen cells. Kloke O; Haubeck HD; Kölsch E Eur J Immunol; 1986 Jun; 16(6):659-64. PubMed ID: 2424769 [TBL] [Abstract][Full Text] [Related]
16. Studies on the immune response to fixed antigens. II. Optimal conditions for inducing and eliciting helper function by fixed antigens and the mechanism responsible for this effect. Naor D; Kahan M Isr J Med Sci; 1977 Jun; 13(6):561-76. PubMed ID: 328450 [TBL] [Abstract][Full Text] [Related]
17. Cell interactions between histoincompatible T an B lymphocytes. IX. The failure of histoincompatible cells is not due to suppression and cannot be circumvented by carrier-priming T cells with allogeneic macrophages. Katz DH; Chiorazzi N; McDonald J; Katz LR J Immunol; 1976 Nov; 117(5 Pt.2):1853-9. PubMed ID: 62793 [TBL] [Abstract][Full Text] [Related]
18. Demonstration of organ differences in peripheral B cell populations through the use of deficient fetal bovine serum. Campbell SM; Kagnoff MF; Watson J J Immunol; 1975 Mar; 114(3):992-6. PubMed ID: 803537 [TBL] [Abstract][Full Text] [Related]
19. Antibody-forming cells with specificity for syngeneic and allogeneic (thymocyte) tissue antigens following lipopolysaccharide mitogenic stimulation. McHugh YH; Bonavida B Transplant Proc; 1977 Mar; 9(1):1205-9. PubMed ID: 68566 [No Abstract] [Full Text] [Related]
20. The importance of serologically detectable histocompatibility antigens in the induction and effector step of cell-mediated lysis. Dennert G; Hyman R Eur J Immunol; 1977 May; 7(5):251-7. PubMed ID: 141372 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]